3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Biltricide: new trials by email Literature Review of Biltricide trials Research Report on Biltricide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni Ujiplus®, Praziquantel 400mg - Schistosoma Mansoni | Phase 2 / Phase 3 | Completed | Kenya Medical Research Institute | 400 | 2021-05-06 | 2022-07-12 |
| Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST) 4x Praziquantel, 1x Praziquantel - Schistosomiasis | Phase 3 | Completed | Leiden University Medical Center | 167 | 2018-10-01 | 2020-11-18 |
| A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni Artesunate+Sulfamethoxypyrazine/pyrimethamine, Praziquantel - Schistosoma Mansoni | Phase 3 | Completed | Kenya Medical Research Institute | 212 | 2009-10-01 | 2010-01-22 |
Schistosomiasis (3)
Kenya Medical Research Institute (2) · Leiden University Medical Center (1)
Kenya (2) · Côte d’Ivoire (1)
Elijah M Songok, PhD (1) · Jean Coulibaly (1) · Pauline N Mwinzi, PhD (1)
PMID 20705516, PMID 32196506, PMID 36548444
2016 (1)